Drug Class
tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
lenvatinib
📋Overview
Lenvatinib is a targeted therapy drug that inhibits multiple receptor tyrosine kinases involved in tumor growth and angiogenesis. It is primarily associated with the treatment of certain types of cancers, including thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. By blocking specific signaling pathways, lenvatinib helps to slow the progression of malignant cells. Its use is typically considered in cancers that are advanced or have not responded to other treatments.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Lenvatinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.